Skip to main content

Myriad Genetics, Inc. (NASDAQ: MYGN) Investor Securities Class Action Lawsuit 10/02/2019

  • If you purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 16, 2021 - The court denied the defendants' motion to dismiss. May 5, 2020 - A motion to dismiss the amended complaint was filed. February 21, 2020 - An amended complaint was filed. September 27, 2019 - An investor in shares of Myriad Genetics, Inc. (NASDAQ: MYGN) filed a lawsuit in the U.S. District Court for the District of Utah over alleged violations of Federal Securities La...



You must register (for free) or login to view the entire case.